Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
25 Cards in this Set
- Front
- Back
What is measured for Growth Hormone deficiency diagnosis?
|
GHRH
|
|
What is used for treating GH deficiency?
|
rGH - recombinant
|
|
What is used for treatment of acromegaly?
|
Octreotide
|
|
Octreotide is:
|
Somatostatin analog
|
|
What is used for treatment of acromegaly if not an SST analog?
|
Pegvisomant
|
|
Pegvisomant is:
|
GH receptor antagonist
|
|
How is GH release from the pituitary regulated? (pos vs neg)
|
Pos: stim by GHrH from hypothal
Neg: inhib by SST from hypothal |
|
What inhibits GHRH release from the hypothal?
|
GH negative feedback
|
|
What stimulates SST release from the hypothal?
|
IGF1 from the liver
|
|
Where did IGF1 from the liver come from?
|
Stimulation by GH from the pituitary
|
|
How is GH deficiency diagnosed?
|
By injecting GHRH and looking for the responsive GH production
|
|
What will be the result of GHRH injection in a GH deficient patient?
|
Subnormal GH release from the pituitary
|
|
When will a kid with GH deficiency start to fall off the growth curves?
|
Between the age of 1-3
|
|
What drug is used for treating GH deficiency?
|
hGH - human or recombinant GH
|
|
What is used for treating Acromegaly?
|
Octreotide
|
|
What is Octreotide?
|
A somatostatin analog
|
|
What is another SST analog?
|
Lanreotide
|
|
What does an SST analog do?
|
inhibits the pituitary so that GH release is decreased
|
|
What causes acromegaly?
|
GH secreting pituitary adenomas
|
|
What is measured to diagnose acromegaly?
|
IGF1 levels
|
|
What are 2 things that Octreotide does in treating GH-secreting pituitary adenomas?
|
-Inhibits GH release
-Shrinks the tumor to allow for better surgical resection |
|
What is a last resort treatment for Acromegaly?
|
Pegvisomant
|
|
What is Pegvisomant?
|
GH-receptor antagonist
|
|
What is achieved by antagonism of GH receptors?
|
It inhibits GH from stimulating liver production of IGF1 so the levels of IGF1 are decreased
|
|
Why is pegvisomant a last resort?
|
Because by blocking IGF1 production, it reduces SST from hypothal, so that it may actually increase pituitary GH release and tumor size.
|